Pigment Cell & Melanoma Research

Papers
(The median citation count of Pigment Cell & Melanoma Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information99
48
37
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells35
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy32
Let’s talk about sex: A biological variable in immune response against melanoma25
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes25
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing25
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma23
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)22
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies22
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis20
Issue Information20
25th International Pigment Cell Conference, Bilbao, Spain IPCC 202317
Issue Information17
Issue Information17
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes16
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 616
Progress in melanoma treatment: Patient's perspectives14
Abstracts14
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma14
Corrigendum13
13
Corrigendum13
Issue Information13
Issue Information12
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database12
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma12
PASPCR 2024 Annual Meeting, New York, NY12
Single‐cell profiling of MC1R‐inhibited melanocytes11
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling11
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend11
Cover Image10
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population10
10
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes8
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models8
BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells8
7
Issue Information7
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 20237
7
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma7
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages7
Issue Information6
Cover Image6
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐16
Cover Image6
The delicate relation between melanocytes and skin immunity: A game of hide and seek6
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo5
The metabolism of melanin synthesis—From melanocytes to melanoma5
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production5
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model5
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment5
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 20155
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma5
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation5
Issue Information5
Topical antibiotics limit depigmentation in a mouse model of vitiligo5
Special issue: “Biology of skin pigmentation and pigmentary diseases”5
Three‐dimensional imaging for the analysis of human epidermal melanocytes5
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines4
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity4
ToFSIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma4
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab4
Cutaneous Pigment Cell Distributions and Skin Structure of Xenopus4
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism4
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation4
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants4
TFE3 promotes ferroptosis in melanoma4
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era4
Advancements in melanoma cancer metastasis models4
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/64
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance4
Issue Information4
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment4
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis4
Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas3
Interplay of Light, Melatonin, and Circadian Genes in Skin Pigmentation Regulation3
Corrigendum3
Issue Information3
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State3
Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line3
3
Issue Information3
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy3
Myron Gordon Award Lecture 2023: Painting the neural crest: How studying pigment cells illuminates neural crest cell biology3
New Dermoscopy Pattern in Nevus‐Associated Melanomas3
Conjunctival Melanoma: A Narrative Review of Current Knowledge3
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)3
Primary cutaneous melanoma in Black patients: An analysis of 2464 cases from the National Cancer Database 2004–20183
3
3
Xenopus as a model system for studying pigmentation and pigmentary disorders3
Optimisation of skin phototype classification3
Piceatannol—Can It Be Used to Treat Hyperpigmentation of the Skin?3
3
Issue Information2
Melanoma and Matrimony: Retrospective Study of Demographics, Marital Status, and Clinical Features of Patients With Acral Melanoma at a Single Academic Center2
The Role of Two Tyrosinase‐Like Glycoenzymes in Defining the Final Hue of Parrot Plumage2
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)2
In Memoriam: Rajasekharan (Shyam) Somasundaram (1956–2021)2
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study2
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care2
The classification of melanocytic gene signatures2
In Memoriam: Soldano Ferrone MD, PhD (1940–2023)2
The Yucatan miniature swine as a model for post‐inflammatory hyperpigmentation2
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas2
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma2
X and Y Differences in Melanoma Survival Between the Sexes2
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage2
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment2
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations2
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors2
Protein‐based classification of melanoma differentiation subtypes2
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities2
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study2
Trained immunity in the pathogenesis of vitiligo2
Cover Image2
RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response2
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation2
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features2
An in vitro nevus explant model for studying the effects of ultraviolet radiation2
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants1
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)1
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features1
Cover Image1
List of Reviewers for PCMR1
The MITF regulatory network in melanoma1
Clinicopathological features and associations in a series of South African acral melanomas1
The 21st International Congress of the Society for Melanoma Research1
Cholinergic Signaling Mediated by Muscarinic Receptors Triggers the Ultraviolet‐Induced Release of Melanosome in Cultured Melanoma Cells1
List of reviewers for PCMR (01.01.2023–30.09.2023)1
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort1
Epilogue1
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity1
Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus1
Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series1
The Incorporation of Melanosomes by Senescent Keratinocytes Causes the Accumulation of Melanin due to Decreased Energy Metabolism1
1
Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children1
Genotypic spectrum of albinism in Mali1
Cancer‐Associated Fibroblast Signature Can Predict Prognosis and Therapeutic Responses in Skin Cutaneous Melanoma1
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL1
1
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis1
0.07146692276001